Dr. Burnett received his M.D. from Duke University and concurrently obtained an M.B.A. from Duke’s Fuqua School of Business. Since 2006 Dr. Burnett has raised, or helped raise, over $250 MM for the fourteen TheraNova spinouts. He is an inventor on 57 issued patents and over 180 patents pending worldwide. He recently joined University of California San Francisco as an entrepreneur in residence with QB3 and as adjunct faculty in the Bioengineering Department.
A device-based approach to Alzheimer’s is novel. We are excited to be working with Morningside, which has shown an unwavering commitment to bringing this technology all the way into the clinic.10 March 2021